Pulse 탐색 nav.journalClub 토론 트렌드 연구자

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

홈 탐색 nav.journalClub 트렌드

⌘+K

Type 1 diabetes immunotherapy using polyclonal regulatory T cells | Synapse

November 25, 2015

View Full Paper

Type 1 diabetes immunotherapy using polyclonal regulatory T cells

Jeffrey A. BluestoneNorthwestern University JBJane H. BucknerVirginia Mason Medical Center MFMark FitchUniversity of California, Berkeley

Key Points

Key points are not available for this paper at this time.

Abstract

Autologous regulatory T cells can be expanded and are well tolerated in patients with recent-onset type 1 diabetes.

AI에게 질문

Like

Bookmark

Share

View Full Paper

Cite This Study

Bluestone et al. (Wed,) studied this question.

synapsesocial.com/papers/69d8a20c183921ebcaae3041 https://doi.org/https://doi.org/10.1126/scitranslmed.aad4134

AI에게 질문

Like

Bookmark

Share

View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1DNA demethylation in the human <i>FOXP3</i> locus discriminates regulatory T cells from activated FOXP3<sup>+</sup> conventional T cells2007 · 681 citations
2CD56negCD16+NK cells are activated mature NK cells with impaired effector function during HIV-1 infection2013 · 118 citations
3Survival and Tumor Localization of Adoptively Transferred Melan-A-Specific T Cells in Melanoma Patients2003 · 158 citations
4Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry2015 · 1,253 citations
5Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus2007 · 570 citations